Tumor rim cells: From resistance to vascular targeting agents to complete tumor ablation.

Abstract

Current vascular targeting strategies pursue two main goals: anti-angiogenesis agents aim to halt sprouting and the formation of new blood vessels, while vascular disrupting agents along with coaguligands seek to compromise blood circulation in the vessels. The ultimate goal of such therapies is to deprive tumor cells out of oxygen and nutrients long enough… (More)
DOI: 10.1177/1010428317691001

Topics

Cite this paper

@article{Seidi2017TumorRC, title={Tumor rim cells: From resistance to vascular targeting agents to complete tumor ablation.}, author={Khaled Seidi and Rana Jahanban-Esfahlan and Nosratollah Zarghami}, journal={Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine}, year={2017}, volume={39 3}, pages={1010428317691001} }